Current Illinois CancerCare Clinical Trials

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver (Temporarily Closed)

Study Number: EA2187 (Temporarily Closed)

Study Summary:
This phase II trial studies how well pevonedistat alone or in combination with chemotherapy (paclitaxel and carboplatin) works in treating patients with bile duct cancer of the liver. Pevonedistat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This study may help the study doctors find out how well pevonedistat shrinks bile duct cancer of the liver when given alone and when in combination with paclitaxel and carboplatin. (Temporarily Closed)

Status: Suspended

Just in Time Trial

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621

Study Link

« Search Again